News
Researchers have found in a new research that children with inflammatory skin conditions such as atopic dermatitis, psoriasis ...
Children with early-onset atopic dermatitis (AD) have an elevated risk for pediatric uveitis, according to a study published ...
2d
Zacks Small Cap Research on MSNLGND: Pelthos To Become Public CompanyLGND READ THE FULL LGND RESEARCH REPORT Ligand Pharmaceuticals, Inc. (NASDAQ:LGND) announced that it had identified a suitor to take its subsidiary Pelthos Therapeutics public in an April 17th press ...
A new study in Scientific Reports reveals that skin shame is a key psychological burden for people with atopic dermatitis and ...
In adults with atopic dermatitis, moisturizers with anti-inflammatory ingredients significantly improved skin hydration and ...
Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on ...
Children with inflammatory skin diseases are at an increased risk for sleep and psychological disorders, prompting clinicians ...
A panelist discusses how real-world data presented at the 2025 American Academy of Dermatology Annual Meeting (AAD 2025) ...
Approval based on Phase 3 trials demonstrating Dupixent significantly reduced itch and hives compared to placebo In the U.S., there are more than ...
Many people experience an itchy scalp at some point. It’s usually not a sign of a serious medical condition and can, in most ...
Arcutis Biotherapeutics, Inc.’s ARQT share price has surged by 5.09%, which has investors questioning if this is right time to sell.
Evommune launches mid-stage trials for immune-modulating drugs targeting skin conditions, backed by $115M funding and led by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results